Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Klage von Großgläubiger lässt Cable One-Aktie abstürzen (Investing.com DE) +++ CABLE ONE Aktie -9,00%

ELANCO Aktie

 >ELANCO Aktienkurs 
20.45 EUR    (TradegateBSX)
Ask: 20.5 EUR / 980 Stück
Bid: 20.4 EUR / 980 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ELANCO Aktie über LYNX handeln
>ELANCO Performance
1 Woche: +1,8%
1 Monat: -4,6%
3 Monate: -6,4%
6 Monate: -2,1%
1 Jahr: +13,5%
laufendes Jahr: +2,7%
>ELANCO Aktie
Name:  ELANCO ANIMAL HEALTH.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US28414H1032 / A2N6BH
Symbol/ Ticker:  5EA (Frankfurt) / ELAN (NYSE)
Kürzel:  FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN
Index:  -
Profil:  Elanco Animal Health Incorporated is an animal health company focused on developing, manufacturing, and marketing products for pets and farm animals. Its portfolio includes treatments and preventive solutions for parasitic control, dermatology, pain ..
>Volltext..
Marktkapitalisierung:  9962.19 Mio. EUR
Unternehmenswert:  12924.19 Mio. EUR
Umsatz:  4476.57 Mio. EUR
EBITDA:  914.93 Mio. EUR
Nettogewinn:  -177.46 Mio. EUR
Gewinn je Aktie:  -0.36 EUR
Schulden:  3493.86 Mio. EUR
Liquide Mittel:  472.63 Mio. EUR
Operativer Cashflow:  550.21 Mio. EUR
Bargeldquote:  0.29
Umsatzwachstum:  15.48%
Gewinnwachstum:  -147.3%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ELANCO
Letzte Datenerhebung:  09.10.26
>ELANCO Kennzahlen
Aktien/ Unternehmen:
Aktien: 499.62 Mio. St.
Frei handelbar: 98.98%
Rückkaufquote: -
Mitarbeiter: 9900
Umsatz/Mitarb.: 0.42 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 42.38%
Bewertung:
KGV: -
KGV lG: 19.28
KUV: 2.2
KBV: 1.69
PEG-Ratio: -
EV/EBITDA: 14.13
Rentabilität:
Bruttomarge: 44.28%
Gewinnmarge: -3.96%
Operative Marge: 6.63%
Managementeffizenz:
Gesamtkaprendite: -1.46%
Eigenkaprendite: -2.98%
>ELANCO Peer Group
Gesundheit, Hauterkrankungen & -behandlung/ Dermatologie, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika, Tiermedizin/ Tierbehandlung
 
09.10.26 - 17:42
The Veterinary Cooperative and Elanco Donate $14,088 to The Street Dog Coalition (Business Wire)
 
Paws for a Cause fundraiser at TVC VetVision™ 2026 turns cooperative principle of Concern for Community into meaningful support for pets and people experiencing homelessness Release Summary The Veterinary Cooperative raised $7,044 for The Street Dog Coalition through its Paws for a Cause: Bingo Night fundraiser at TVC VetVision™ 2026. Elanco Animal Health matched TVC's donation, bringing the total contribution to $14,088. Based on The Street Dog Coalition's 2026 average cost of care, the combined contribution can help provide free veterinary care for more than 120 pets. The fundraiser reflects TVC's commitment to the seventh cooperative principle, Concern for Community, through support for animal welfare and the communities its members serve.  EVANSTON, Ill.--(BUSINESS WIRE)--The Veterinary Cooperative (TVC), a member-owned cooperative supporting independent veterinary practices across the United States, today announced a combined $14,088 donation to The Street Dog Coalition following its Paws for...
07.10.26 - 17:42
One Health Innovation District Breaks Ground on One Health Research Institute, Anchored by Purdue University and Elanco Animal Health (Accesswire)
 
Purpose-built research, incubator and laboratory space will leverage Purdue's R1 capabilities and Elanco's animal health leadership to advance One Health innovation in Indianapolis INDIANAPOLIS, IN......
22.09.26 - 16:12
Elanco auf der Bank of America Konferenz: Wachstum, Produktpipeline und Schuldenabbau im Fokus (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
15.09.26 - 18:18
Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care (Accesswire)
 
Innovation that protects against these pests is driving stronger Elanco base business and overall share gains.Elanco confirms U.S. Pet Health is on track to expectations of high-single digit to low......
11.09.26 - 14:00
Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement (PR Newswire)
 
INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail......
10.09.26 - 14:00
Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference (PR Newswire)
 
INDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Jeff Simmons, president and CEO, Bob VanHimbergen, executive vice president and CFO, and Bobby Modi,......
04.09.26 - 22:48
Elanco Director Purchases 40,000 Shares for $936,000 (Fool)
 
Purchasing 40,000 shares is a bullish signal for shareholders....
31.08.26 - 15:42
Elanco Scales Biologics Capabilities With Expansion of Kansas Manufacturing Facility (Accesswire)
 
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline INDIANAPOLIS, IN / ACCESS Newswire / Aug......
26.08.26 - 14:33
Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility (PR Newswire)
 
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline INDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the on-time completion of......
22.08.26 - 05:01
Insiderhandel: Aufsichtsrat kauft Aktien von Elanco Animal Health im Wert von 935920 USD (Insiderkauf)
 
Kurzius, Lawrence Erik - Aufsichtsrat - Tag der Transaktion: 2026-08-20...
19.08.26 - 16:00
Director′s Confidence Visible as Elanco Leader Buys 10,000 Shares (Fool)
 
Insider buys into strength as the Elanco stock price has outperformed the S&P 500 over the last 12 months....
19.08.26 - 05:01
Insiderhandel: GC AND CORP SEC kauft Aktien von Elanco Animal Health im Wert von 94273 USD (Insiderkauf)
 
O'neill, Shiv - Vorstand - Tag der Transaktion: 2026-08-18...
14.08.26 - 01:01
Insiderhandel: Aufsichtsrat kauft Aktien von Elanco Animal Health im Wert von 109100 USD (Insiderkauf)
 
Harrington, Michael J. - Aufsichtsrat - Tag der Transaktion: 2026-08-12...
13.08.26 - 20:36
Elanco: Fitch hebt Rating wegen erfolgreichen Schuldenabbaus an (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.08.26 - 13:48
Elanco (ELAN) Q2 2026 Earnings Call Transcript (Fool)
 
Zenrelia and Credelio Quattro drove blockbuster growth and margin expansion....
11.08.26 - 16:30
Elanco′s CLiK Extra Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species (Accesswire)
 
Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical expertsEmergency Use Authorization for Elanco's CLiK Extra p......
11.08.26 - 00:01
Insiderhandel: EVP and CFO kauft Aktien von Elanco Animal Health im Wert von 96926 USD (Insiderkauf)
 
Vanhimbergen, Robert M. - Vorstand - Tag der Transaktion: 2026-08-07...
11.08.26 - 00:01
Insiderhandel: Aufsichtsrat kauft Aktien von Elanco Animal Health im Wert von 236850 USD (Insiderkauf)
 
Herendeen, Paul - Aufsichtsrat - Tag der Transaktion: 2026-08-07...
07.08.26 - 20:24
Elanco′s CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Specie (PR Newswire)
 
Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital tool in the prevention of New World screwworm......
07.08.26 - 15:54
Elanco granted FDA’s emergency nod for new world screwworm drug (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Früh zur Mühle und spät zur Kirche, so kommt man bald zurück. - Sprichwort Finnland
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!